These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7736856)

  • 21. Indigenous self-determination in an age of genetic patenting: recognizing an emerging human rights norm.
    Ching KH
    Fordham Law Rev; 1997 Nov; 66(2):687-730. PubMed ID: 10182427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intellectual property rights, benefit-sharing and development of "improved traditional medicines": A new approach.
    Willcox M; Diallo D; Sanogo R; Giani S; Graz B; Falquet J; Bodeker G
    J Ethnopharmacol; 2015 Dec; 176():281-5. PubMed ID: 26528586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Traditional knowledge and intellectual property.
    Brody BA
    Kennedy Inst Ethics J; 2010 Sep; 20(3):231-49. PubMed ID: 21133334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indigenous heritage and biopiracy in the age of intellectual property rights.
    Tedlock B
    Explore (NY); 2006 May; 2(3):256-9. PubMed ID: 16781652
    [No Abstract]   [Full Text] [Related]  

  • 25. Managing genetic material to protect intellectual property rights.
    Jong SC; Cypess RH
    J Ind Microbiol Biotechnol; 1998 Feb; 20(2):95-100. PubMed ID: 9611821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intellectual property rights, the World Trade Organization and public health: the Brazilian perspective.
    Viana JM
    Conn J Int Law; 2002; 17(2):311-8. PubMed ID: 12688298
    [No Abstract]   [Full Text] [Related]  

  • 27. The position of intellectual property rights in drug discovery and development from natural products.
    Boyd MR
    J Ethnopharmacol; 1996 Apr; 51(1-3):17-25; discussion 25-7. PubMed ID: 9213613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Research on the pharmaceutical intellectual property protection and supervision of pharmacy administration.
    Xu Z; Chen W
    Pak J Pharm Sci; 2017 May; 30(3(Special)):1081-1087. PubMed ID: 28671085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intellectual property rights in Costa Rica in the light of the Biodiversity Convention].
    Salazar R; Cabrera JA
    J Ethnopharmacol; 1996 Apr; 51(1-3):177-93. PubMed ID: 9213615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patenting bioactive molecules from biodiversity: the Brazilian experience.
    Nogueira RC; de Cerqueira HF; Soares MB
    Expert Opin Ther Pat; 2010 Feb; 20(2):145-57. PubMed ID: 20099999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intellectual property rights and the Canadian pharmaceutical marketplace: where do we go from here?
    Lexchin J
    Int J Health Serv; 2005; 35(2):237-56. PubMed ID: 15932005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. North-South benefit sharing arrangements in bioprospecting and genetic research: a critical ethical and legal analysis.
    Schüklenk U; Kleinsmidt A
    Dev World Bioeth; 2006 Dec; 6(3):122-34. PubMed ID: 17038004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Language revitalization in Native North America--issues of intellectual property rights and intellectual sovereignty.
    Tatsch S
    Coll Antropol; 2004; 28 Suppl 1():257-62. PubMed ID: 15156749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human-tissue-related inventions: ownership and intellectual property rights in international collaborative research in developing countries.
    Andanda PA
    J Med Ethics; 2008 Mar; 34(3):171-9. PubMed ID: 18316458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medicines in the forest: Ethnobotany of wild medicinal plants in the pharmacopeia of the Wichí people of Salta province (Argentina).
    Suárez ME
    J Ethnopharmacol; 2019 Mar; 231():525-544. PubMed ID: 30414441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patenting biotechnologies: the European Union Directive 98/44/EC of the European parliament and of the council of 6th July 1998 on the legal protection of biotechnological inventions.
    Morelli Gradi G
    Forum (Genova); 1999; 9(3 Suppl 3):25-36. PubMed ID: 10607844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of the legal regime of intellectual property protection in the pharmaceutical market.
    Pashkov VM; Golovanova IA; Olefir AA
    Wiad Lek; 2016; 69(3 pt 2):582-586. PubMed ID: 27717949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overcoming epistemic injustices in the biomedical study of ayahuasca: Towards ethical and sustainable regulation.
    Schenberg EE; Gerber K
    Transcult Psychiatry; 2022 Oct; 59(5):610-624. PubMed ID: 34986699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Patents in pharmaceutical industry: between ethics and property rights].
    Martínez Cárdenas EE
    Rev Salud Publica (Bogota); 2003; 5(1):18-23. PubMed ID: 14658364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obtaining, challenging and enforcing pharmaceutical patents under the America Invents Act.
    Genieser LH; McCann CE
    Pharm Pat Anal; 2012 Sep; 1(4):415-26. PubMed ID: 24236880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.